ITLN1 and prostate cancer: Ectopic expression of ITLN1 into prostate cancer cells results in significantly decreased in vitro cell viability; meanwhile, increased tumorigenicity and in vivo growth are observed in ITLN1 knockdown prostate cancer cells, indicating a tumor suppressive role of ITLN1 in prostate cancer [24].